JIC
ULBI icon

Joel Isaacson & Co’s Ultralife ULBI Stock Holding History

Joel Isaacson & Co’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-750
Closed -$3K – 521
2013
Q3 		$3K Hold
750
– – ﹤0.01% 464
2013
Q2 		$3K Buy
+750
New +$2.93K ﹤0.01% 432

Other funds holding ULBI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Joel Isaacson & Co's ULBI Position: Q4 2013 in Review

Joel Isaacson & Co sold out of Ultralife (ULBI) in Q4 2013, closing a stake of 750 shares — an estimated $3K sold.

Joel Isaacson & Co first reported a position in ULBI in Q2 2013 and held it in 2 quarters. The position peaked at $3K in Q3 2013. 38 funds tracked by Wall St. Rank hold ULBI as of Q4 2013.

  • Joel Isaacson & Co reported no remaining Ultralife position as of Q4 2013 after selling out during the quarter.
  • Joel Isaacson & Co sold 750 Ultralife shares in Q4 2013, an estimated $3K.
  • Joel Isaacson & Co first reported a position in Ultralife in Q2 2013 and held it in 2 quarters.
  • Joel Isaacson & Co's Ultralife position peaked at $3K in Q3 2013.
  • 38 funds tracked by Wall St. Rank held Ultralife as of Q4 2013.

Based on Joel Isaacson & Co's 13F filing for Q4 2013, filed 12 Feb 2014.